Human chorionic gonadotropin that is widely used for improving spermatogenesis. The effect of chorionic gonadotropin is mediated through luteinizing hormone receptor. Treatment with gonadotropin is associated with undesirable effects due to hyperactivation of testosterone production and luteinizing hormone receptor desensitization. A promising alternative could be low-molecular-weight agonists of luteinizing hormone receptors, but their effects on spermatogenesis have not been investigated. Here we analyzed the effect of a thieno[2,3-d]pyrimidines (TP), 4-((3-(5-amino-6-(tert-butylcarbamoyl)-2-(methylthio)thieno [2,3-d]pyrimidine-4-yl) phenyl)carbamoyl)pyridine 1-oxide (TP22), an allosteric agonist of luteinizing hormone receptors, on the seminiferous tubules and spermatogenic cells in 4- and 18-month-old male rats and in animals with diabetes mellitus. TP22 and gonadotropin were administered in daily doses of 15 mg/kg and 20 U/rat for 5 days. Blood testosterone level, morphology of the seminiferous tubules, and the number of germ cells in them were estimated. Being comparable by the efficiency to gonadotropin, TP22 increased the testosterone level in all the studied groups of rats and restored epithelium thickness in the seminiferous tubules and the number of spermatogonia and pachytenic spermatocytes that are reduced in aging and diabetes, but, unlike gonadotropin, did not suppress the expression of luteinizing hormone receptor. The efficacy of TP22 as a stimulator of testicular spermatogenesis has been demonstrated both under normal conditions and in age-related and diabetes-associated reproductive dysfunctions.
Similar content being viewed by others
References
Bakhtyukov AA, Derkach KV, Sharova TS, Shpakov AO, Dar’in DV. Decrease in the basal and luteinizing hormone receptor agonist-stimulated testosterone production in aging male rats. Adv. Gerontol. 2019;9(2):179-185. doi: https://doi.org/10.1134/S2079057019020036
Bakhtyukov AA, Derkach KV, Stepochkina AM, Shpakov AO, Dar’in DV. A low molecular weight agonist of the luteinizing hormone receptor stimulates adenylyl cyclase in the testicular membranes and steroidogenesis in the testes of rats with type 1 diabetes. Biochemistry (Mosc). Suppl. Ser. A: Membr. Cell Biol. 2019;13(4):301-309. https://doi.org/10.1134/S1990747819040032
Derkach KV, Shpakov AO, Legkodukh AS, Dar’in DV. The stimulating effect of thienopyrimidines structurally similar to ORG 43553 on adenylate cyclase activity in the testes and on testosterone production in male rats. Cell Tissue Biol. 2017;11(1):73-80. https://doi.org/10.1134/S1990519X17010035
Gunes S, Hekim GN, Arslan MA, Asci R. Effects of aging on the male reproductive system. J. Assist. Reprod. Genet. 2016;33(4):441-454. https://doi.org/10.1007/s10815-016-0663-y
Jangir RN, Jain GC. Diabetes mellitus induced impairment of male reproductive functions: a review. Curr. Diabetes Rev. 2014;10(3):147-157. https://doi.org/10.2174/1573399810666140606111745
Nataraja SG, Yu HN, Palmer SS. Discovery and development of small molecule allosteric modulators of glycoprotein hormone receptors. Front. Endocrinol. (Lausanne). 2015;6:142. https://doi.org/10.3389/fendo.2015.00142
Newton CL, Whay AM, McArdle CA, Zhang M, van Koppen CJ, van de Lagemaat R, Segaloff DL, Millar RP. Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonist. Proc. Natl Acad. Sci. USA. 2011;108(17):7172-7176. https://doi.org/10.1073/pnas.1015723108
Pitteloud N, Dwyer A. Hormonal control of spermatogenesis in men: therapeutic aspects in hypogonadotropic hypogonadism. Ann. Endocrinol. (Paris). 2014;75(2):98-100. https://doi.org/10.1016/j.ando.2014.04.002
Riccetti L, Yvinec R, Klett D, Gallay N, Combarnous Y, Reiter E, Simoni M, Casarini L, Ayoub MA. Human luteinizing hormone and chorionic gonadotropin display biased agonism at the LH and LH/CG receptors. Sci. Rep. 2017;7(1):940. https://doi.org/10.1038/s41598-017-01078-8
Roelfsema F, Yang RJ, Liu PY, Takahashi PY, Veldhuis JD. Feedback on LH in testosterone-clamped men depends on the mode of testosterone administration and body composition. J. Endocr. Soc. 2018;3(1):235-249. https://doi.org/10.1210/js.2018-00317
Shi GJ, Li ZM, Zheng J, Chen J, Han XX, Wu J, Li GY, Chang Q, Li YX, Yu JQ. Diabetes associated with male reproductive system damages: Onset of presentation, pathophysiological mechanisms and drug intervention. Biomed. Pharmacother. 2017;90:562-574. https://doi.org/10.1016/j.biopha.2017.03.074
Shokoohi M, Shoorei H, Soltani M, Abtahi-Eivari SH, Salimnejad R, Moghimian M. Protective effects of the hydroalcoholic extract of Fumaria parviflora on testicular injury induced by torsion/detorsion in adult rats. Andrologia. 2018;50(7):e13047. https://doi.org/10.1111/and.13047
van de Lagemaat R, Raafs BC, van Koppen C, Timmers CM, Mulders SM, Hanssen RG. Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH. Endocrinology. 2011;152(11):4350-4357. https://doi.org/10.1210/en.2011-1077
van Koppen CJ, Zaman GJ, Timmers CM, Kelder J, Mosselman S, van de Lagemaat R, Smit MJ, Hanssen RG. A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor. Naunyn Schmiedebergs Arch. Pharmacol. 2008;378(5):503-514. https://doi.org/10.1007/s00210-008-0318-3
Veldhuis JD, Liu PY, Takahashi PY, Keenan DM. Dynamic testosterone responses to near-physiological LH pulses are determined by the time pattern of prior intravenous LH infusion. Am. J. Physiol. Endocrinol. Metab. 2012;303(6):E720-E728. https://doi.org/10.1152/ajpendo.00200.2012
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 171, No. 1, pp. 100-105, January, 2021
Rights and permissions
About this article
Cite this article
Derkach, K.V., Romanova, I.V., Bakhtyukov, A.A. et al. The Effect of Low-Molecular-Weight Allosteric Agonist of Luteinizing Hormone Receptor on Functional State of the Testes in Aging and Diabetic Rats. Bull Exp Biol Med 171, 81–86 (2021). https://doi.org/10.1007/s10517-021-05177-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-021-05177-5